Results 221 to 230 of about 209,971 (329)

Nanosensors in Leukemia Management: Pioneering Real‐Time Biomarker Detection for Precision Oncology

Nano Select, EarlyView.
This review highlights pioneering nanosensors designed for real‐time leukemia biomarker detection, integrating advanced nanomaterials such as liposomes, polymeric nanoparticles and quantum dots. It examines electrochemical, optical and magnetic detection mechanisms, the applications across AML, ALL, CML, and CLL subtypes, and clinical translation ...
Hamed Soleimani Samarkhazan, Mohammad Navid Khaksari, Amirhossein Mirzazadeh, Mohammad Siavashi, Niloofar Pilehvari, Mohammad Hossein Mohammadi   +5 more
wiley   +1 more source

SSRP1/SLC3A2 Axis in Arginine Transport: A New Target for Overcoming Immune Evasion and Tumor Progression in Peripheral T-Cell Lymphoma. [PDF]

Adv Sci (Weinh)
Ren Y, Fan L, Wang L, Liu Y, Zhang J, Wang B, Chen R, Chen X, Zhuang L, Zhang Y, Sun H, Li J, Shi W, Jin H.   +13 more
europepmc   +1 more source

Multiple cytokine‐producing peripheral T‐cell lymphoma [PDF]

, 2008
Shoko Nakayama, Taiji Yokote, Kichinosuke Kobayashi, Takayuki Takubo, Motomu Tsuji, Toshiaki Hanafusa   +5 more
openalex   +1 more source

A comprehensive review on adaptive plasticity and recovery mechanisms post‐acquired brain injury

Neuroprotection, EarlyView.
This figure illustrates the dynamic process of neurogenesis following brain injury, focusing on the roles of neural stem and progenitor cells at the injury site. Key mechanisms include axonal sprouting, synaptogenesis, dendritic remodeling, and brain‐derived neurotrophic factor signaling via TrkB receptors.
Ravi Kumar Rajan
wiley   +1 more source

Clinical Features and Outcomes of Primary Cutaneous Peripheral T-Cell Lymphoma, Not Otherwise Specified, Treated with CHOP-Based Regimens. [PDF]

Cancers (Basel)
Hu G, Song Z, Lv C, Sun Y, Zhang Y, Liu X, Han X, Li L, Qiu L, Qian Z, Zhou S, Gong W, Meng B, He J, Wang X, Zhang H.   +15 more
europepmc   +1 more source

Lymphoid Malignancies in Ataxia–Telangiectasia: Experience with Novel Targeted Therapies

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Patients with ataxia–telangiectasia (AT) face unique challenges in managing lymphoid malignancies due to heightened sensitivity to chemotherapy and radiation, requiring alternative treatment strategies. This report presents three cases demonstrating the successful integration of targeted therapies: ibrutinib for diffuse large B‐cell lymphoma ...
Samanta Catueno, Ramya Ramakrishnan, Sarah Elitzur, Miriam B. Garcia, David McCall, Cesar Nunez, Michael Roth, Alessandra Ferrajoli, Branko Cuglievan, Amber Gibson   +9 more
wiley   +1 more source

Peripheral T-cell lymphoma-NOS in children and adolescents: a review from the Children's Oncology Group NHL Committee. [PDF]

Blood Adv
Devine KJ, Schwartz L, El-Mallawany NK.
europepmc   +1 more source

Peripheral T-cell Lymphoma-Unspecified (PTCL-U) Presenting with Hypereosinophilic Syndrome and Pleural Effusions

, 2006
Won Ku Choi, Winnie Yeo, Kwang Hyun Paik, Yoon Hwan Chang, Seung‐Sook Lee, Baek‐Yeol Ryoo, Sung Hyun Yang   +6 more
openalex   +1 more source

High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus [PDF]

, 2009
Sylvia Hartmann, Stefan Gesk, René Scholtysik, Markus Kreuz, Stefanie Bug, Inga Vater, Claudia Döring, Sergio Cogliatti, Marie Parrens, Jean‐Philippe Merlio, Anna Kwiecińska, Anna Porwit, Pier Paolo Piccaluga, Stefano Pileri, Gerald Höefler, Ralf Küppers, Reiner Siebert, Martin‐Leo Hansmann   +17 more
openalex   +1 more source

Semi‐mechanistic population PK/PD model to aid clinical understanding of myelodysplastic syndromes following treatment with Venetoclax and Azacitidine

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 448-459, March 2025.
Abstract Myelodysplastic syndromes (MDS) represent a group of bone marrow disorders involving cytopenias, hypercellular bone marrow, and dysplastic hematopoietic progenitors. MDS remains a challenge to treat due to the complex interplay between disease‐induced and treatment‐related cytopenias.
Neha Thakre, Corinna Maier, Jiuhong Zha, Benjamin Engelhardt, Johannes E. Wolff, Sven Mensing   +5 more
wiley   +1 more source